Who owns CONDUIT PHARMACEUTICALS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Conduit Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Conduit Pharmaceuticals stock

Who bought or sold CONDUIT PHARMACEUTICALS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Polar Securities 950k $10k 0% Sep 2025
 View chart
Saba Capital Management 765k $9.0k 0% Sep 2025
 View chart
Toronto-Dominion Bank 756k $8.3k 0% Sep 2025
 View chart
MMCAP International Inc. SPC 700k $7.4k 0% Sep 2025
 View chart
Clear Street 535k $5.8k 30% Jun 2025
 View chart
Decagon Asset Management 400k $4.2k 0% Sep 2025
 View chart
D. E. Shaw & Co 375k $4.0k 0% Sep 2025
 View chart
Boothbay Fund Management 250k $170k 0% Sep 2025
 View chart
Atw Spac Management 250k $2.7k 0% Sep 2025
 View chart
Wolverine Asset Management 244k $2.6k 0% Sep 2025
 View chart
Rivernorth Capital Management 200k $2.1k 0% Sep 2025
 View chart
SkyView Investment Advisors 150k $2.0k 0% Jun 2025
 View chart
Context Capital Management 129k $1.4k 0% Sep 2025
 View chart
Susquehanna International 108k $1.2k 100% Sep 2025
 View chart
Periscope Capital 105k $1.1k 0% Sep 2025
 View chart
Millennium Management 35k $365.700000 0% Sep 2025
 View chart
Two Sigma Securities 14k $151.134800 16% Sep 2025
 View chart
UBS Group 622.00 $7.028600 100% Sep 2025
 View chart

Who sold out of Conduit Pharmaceuticals?

Fund or Company Name Date Sold Shares Held Valued At
Citadel Advisors Jun 2025 68k $744.044900
Heights Capital Management Jun 2025 46k $500.560700